Application Number Funding Recommendation Title Score TR3-05501 Recommended---- Local Delivery of Rejuvenated Old Muscle Stem Cells to Increase Strength in Aged Patients 88 TR3-05641 Recommended---- Targeting glioma cancer stem cells with receptor-engineered self-renewing memory T cells 86 TR3-05542 Recommended---- Generation of safe and therapeutically effective human induced hepatocyte-like cells 85 TR3-05568 Recommended---- Direct reprogramming towards vascular progenitors for the treatment of ischemia 85 TR3-05577 Recommended---- Identifying Drugs for Alzheimer's Disease with Human Neurons Made From Human IPS cells 84 TR3-05669 Recommended---- Stem cell based small molecule therapy for Alzheimer's disease 83 TR3-05559 Recommended---- Human ES cell based therapy of heart failure without allogenic immune rejection 82 TR3-05628 Recommended---- Functional Neural Relay Formation by Human Neural Stem Cell Grafting in Spinal Cord Injury 82 TR3-05556 Recommended---- Heart Repair with Human Tissue Engineered Myocardium 80 TR3-05709 Recommended---- Tissue engineered cartilage from autologous, dermis-isolated, adult, stem (DIAS) cells 80 TR3-05603 Recommended---- Multiple Sclerosis therapy: Human Pluripotent Stem Cell-Derived Neural Progenitor Cells 77 TR3-05687 Recommended---- Identification of Novel Therapeutics for Danon Disease Using an iPS Model of the Disease 76 TR3-05569 Recommended---- Autologous iPSC Therapy for Urinary Incontinence 71 TR3-05476 Recommended---- Immune-Matched Neural Stem Cell Transplantation for Pediatric Neurodegenerative Disease 70 TR3-05535 Recommended---- Gene Correction of Autologous Hematopoietic Stem Cells in Artemis Deficient SCID 68 TR3-05626 Not recommended---- Extracellular Matrix Bioscaffold Augmented with Human Stem Cells for Cardiovascular Repair 67 TR3-05541 Not recommended---- Selection of Anti-R-Spondin Antibody for Targeting Cancer Stem Cells 66 TR3-05617 Recommended---- Targeting Stem Cells to Enhance Remyelination in the Treatment of Multiple Sclerosis 66 TR3-05663 Not recommended---- Targeting Glioblastoma Cancer Stem Cells Using a Novel Bispecific Antibody 63 TR3-05567 Not recommended---- Transplantation of stem-cell-derived retinal progenitor and RPE sheets to restore vision 63 TR3-05488 Recommended---- Generation of hepatic cell from placental stem cell for congenital metabolic disorders 62 TR3-05660 Not recommended---- Programming Human ESC-derived Neural Stem Cells with MEF2C for Transplantation in Stroke -- TR3-05465 Not recommended---- Cancer stem cell based therapy with PI-3 kinase inhibitors in medulloblastoma -- TR3-05730 Not recommended---- Monoclonal antibody therapeutic targeting GPR49 expressed on human cancer stem cells -- TR3-05471 Not recommended---- iPSC-derived cellular therapeutics for Friedreich’s ataxia -- TR3-05606 Not recommended---- Human ES cell-derived MGE inhibitory interneuron transplantation for spinal cord injury -- TR3-05676 Recommended---- Molecules to Correct Aberrant RNA Signature in Human Diseased Neurons -- TR3-05593 Recommended---- Direct Cardiac Reprogramming for Heart Regeneration -- TR3-05477 Not recommended---- Translating stem cells into ligaments for regenerative medicine -- TR3-05575 Not recommended---- Development of pluripotent-derived hNSC candidate cells for the treatment of chronic SCI -- TR3-05456 Not recommended---- Discovering Small Molecule Inducers of Alpha- to Beta-cell Transdifferentiation -- TR3-05564 Not recommended---- Developing a drug screening platform for anorexia nervosa with patient-derived neurons -- TR3-05565 Not recommended---- Developing Placental Neural Crest Stem Cells for In Utero Spina Bifida Repair -- TR3-05703 Not recommended---- Neural & Glial precursors & LIF therapy in a model of diffuse axonal injury/brain trauma -- TR3-05558 Not recommended---- Neurosteroid Activation of Endogenous Neural Stem Cells for Neonatal Brain Damage Repair -- TR3-05529 Not recommended---- Meniscal Repair, Regeneration, and Replacement -- TR3-05534 Not recommended---- IPSC-derived Neo-chondrocytes for Cartilage Regeneration in Osteoarthritis -- TR3-05684 Not recommended---- Human iPS Cell-derived Cortical Motor Neurons for Functional Recovery after Stroke -- TR3-05632 Not recommended---- Agonist monoclonal antibody therapeutic activating GPR49 for regenerative medicine -- TR3-05688 Not recommended---- Allogeneic hESC-Derived Neural Stem Cells in Acute Neonatal Hypoxic-Ischemic Brain Injury -- TR3-05661 Not recommended---- Personalized First-choice Antidepressant Selection Technology. --